Journal Article DZNE-2026-00769

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Brain age prediction in generalized anxiety disorder using a convolutional neural network.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Nature Publishing Group London

Translational Psychiatry 16(1), 368 () [10.1038/s41398-026-04078-3]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Higher predicted brain age difference has been associated with several psychiatric disorders. Generalized anxiety disorder (GAD) is associated with markers of accelerated aging. In this study, we determined brain predicted age difference (PAD) in individuals with GAD and healthy controls (HC) as well as group differences in PAD variability using voxel-wise structural MRI. The training dataset included 3511 controls, and the testing dataset included 1595 individuals with GAD and 4552 HC from the ENIGMA-Anxiety GAD Working Group. A convolutional neural network model using four input modalities per subject and a model ensemble approach was used to predict brain age. The PAD was then calculated by subtracting chronological age from the predicted age. Model performance was consistent with other image-based brain age prediction models with similar accuracy across the training set (mean absolute error (MAE) = 2.95 years) and HC in the testing set (MAE = 2.94). We found no evidence of accelerated brain aging in individuals with GAD compared to individuals without GAD, though we did find evidence for greater variation in PAD for individuals with GAD (Levene's test: W = 442.98, p < 0.001) and evidence for greater variability in PAD of those with GAD over 25 years of age. In several exploratory analyses, we found that symptom severity related significantly to PAD, even after controlling for medication and comorbid diagnoses, echoing previous brain age research. These findings underscore the need for consideration of heterogeneity and dimensionality of psychopathology when examining brain age predicted differences.

Keyword(s): Humans (MeSH) ; Generalized Anxiety Disorder (MeSH) ; Convolutional Neural Networks (MeSH) ; Brain: diagnostic imaging (MeSH) ; Brain: pathology (MeSH) ; Female (MeSH) ; Magnetic Resonance Imaging (MeSH) ; Aging: pathology (MeSH) ; Male (MeSH) ; Adult (MeSH) ; Middle Aged (MeSH) ; Case-Control Studies (MeSH) ; Young Adult (MeSH) ; Anxiety Disorders: diagnostic imaging (MeSH)

Classification:

Contributing Institute(s):
  1. Biomarkers of Dementia in the General Population (AG Grabe)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Database coverage:
Medline ; DOAJ ; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > ROS DZNE > ROS DZNE-AG Grabe
Documents in Process
Public records
In process

 Record created 2026-07-20, last modified 2026-07-20


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)